Summaries & Associations of Study Results
TR-449 Triethanolamine
Target Organs and Levels of Evidence
NTP Technical Report Number 449
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| TRIETHANOLAMINE 102-71-6 |
10/30/98 | INTERMEDIATE IN MANUF. SURFACTANTS, TEXTILE SPECIALTIES, WAXES, POLISHES, HERBICIDES, PETROLEUM DEMULSIFIERS,TOILET GOODS, CEMENT ADDITIVES, CUTTING OILS, IN MAKING MINERAL & VEG. OIL EMULSIONS, SOLVENT, PHARMACEUTIC AID (ALKALIZER) (MERCK 1989). | Topical MR: 0, 32, 63, OR 125; FR: 0, 63, 125, OR 250; MM: 0, 200, 630, OR 2000; FM: 0, 100, 300, OR 1000 MG/KG; 60/GROUP | Battelle Columbus Laboratory |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: EQUIVOCAL EVIDENCE | ||||
| MAY HAVE BEEN RELATED: | KIDNEY TUBULAR CELL: ADENOMA 0/50 1/50 4/49 2/50, STEP SECTIONS 1/50 2/50 6/49 4/50 | |||
| NON-NEOPLASTIC LESIONS: | SKIN: ACANTHOSIS; INFLAMMATION; ULCER | |||
| KIDNEY: INCREASED SEVERITY OF HYPERPLASIA | ||||
| FR: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | SKIN: ACANTHOSIS; EPIDERMAL EROSION; INFLAMMATION; ULCER | |||
| MM: INADEQUATE STUDY | ||||
| FM: INADEQUATE STUDY | ||||
Web page last updated on February 10, 2006
